100 Participants Needed

TetraGraph Monitoring for Infants Undergoing Surgery

Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Joseph D. Tobias
Must be taking: NMBAs
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the TetraGraph (TM) NMT Monitor treatment for infants undergoing surgery?

The research highlights the importance of accurate and reliable monitoring during surgery, which can improve patient outcomes by guiding therapy and reducing risks. Although specific data on the TetraGraph (TM) NMT Monitor is not provided, the general effectiveness of advanced monitoring technologies in improving surgical outcomes is supported by the studies.12345

Is TetraGraph Monitoring safe for infants undergoing surgery?

The available research does not specifically address the safety of TetraGraph Monitoring for infants undergoing surgery, but it highlights general concerns about sedation and anesthesia in children, such as the risk of neurotoxicity and respiratory issues. Continuous monitoring and advancements in technology have improved safety during sedation, but specific data on TetraGraph Monitoring is not provided.678910

How is the TetraGraph Monitoring treatment different from other treatments for infants undergoing surgery?

The TetraGraph Monitoring treatment is unique because it specifically monitors neuromuscular transmission (NMT) in infants during surgery, which helps ensure proper muscle relaxation and recovery. This is different from other treatments that focus on sedation or anesthesia without specialized monitoring of neuromuscular function.1112131415

What is the purpose of this trial?

The primary objective of this study is to evaluate the efficacy of train-of-four (TOF) monitoring using the TetraGraph Neuromuscular Transmission Monitor in pediatric patients less than 1 year of age and when feasible to compare it to standard TOF monitoring using a qualitative monitor.

Eligibility Criteria

This trial is for infants under 1 year old who are undergoing surgery. The study aims to include those who can safely undergo neuromuscular transmission monitoring during their procedure.

Inclusion Criteria

I am 1 year old or younger.
I am having surgery that needs general anesthesia and muscle relaxants.
My health is stable enough for surgery.

Exclusion Criteria

Edematous patients
I am a newborn, less than 28 days old.
I have a history of nerve disorders.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo train-of-four (TOF) monitoring using the TetraGraph Neuromuscular Transmission Monitor during surgery

During the surgery

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • TetraGraph (TM) NMT Monitor
Trial Overview The trial is testing the effectiveness of a device called TetraGraph in monitoring muscle response, known as train-of-four (TOF), during surgery in infants compared to standard TOF monitors when possible.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: TetraGraph (TM) NMT MonitorExperimental Treatment1 Intervention
TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Joseph D. Tobias

Lead Sponsor

Trials
24
Recruited
4,000+

References

Application of Narcotrend® monitor for evaluation of depth of anesthesia in infants undergoing cardiac surgery: a prospective control study. [2015]
[Monitoring in pediatric anesthesia]. [2007]
Intraoperative monitoring during vascular surgery. [2019]
Monitoring in neuroanaesthesia: update of clinical usefulness. [2019]
Neuroanesthesia. Innovative techniques and monitoring. [2019]
Pediatric Sedation: Using Secondary Data to Describe Registered Nurse Practice in Radiology. [2020]
Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation. [2018]
Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center. [2021]
The 'dark' side of sedation: 12 years of office-based pediatric deep sedation for electroretinography in the dark. [2013]
10.United Statespubmed.ncbi.nlm.nih.gov
Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Intravenously administered pentobarbital sodium for sedation in pediatric CT. [2013]
12.United Statespubmed.ncbi.nlm.nih.gov
Brief report: methods for acquiring structural MRI data in very young children with autism without the use of sedation. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Sedation, anesthesia, and physiologic monitoring during MR imaging: evaluation of procedures and equipment. [2019]
[Sedative effect of intranasal midazolam in neonates undergoing magnetic resonance imaging: a prospective single-blind randomized controlled study]. [2020]
[Medication and monitoring in young pediatric patients in NMR (nuclear magnetic resonance) studies]. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security